Home
Dashboard
Curated content

Startups & Scaleups
SMEs & Corporates
Investors
Funding rounds
Accelerators
Universities
Governments & Non-profits
More organizations

Matching tool

Contact
FAQ
Privacy

Companies
ADC Therapeutics
Team
Team

ADC Therapeutics

Develops proprietary antibody drugs targeting cancer. Learn more

Launch date

2011

Employees

Market cap

AUD463m

Enterprise valuation

AUD191m (Public information from Sep 2024)

Share price

$3.1 ADCT

Company register number CH-550.1.094.173-1

Epalinges Canton of Vaud (HQ)

http://www.adctherapeutics.com/

https://twitter.com/adctherapeutics https://www.linkedin.com/company/adc-therapeutics/

View job openings

B2B
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
oncology
verified unicorns and $1b exits
genetics
dna
genome engineering
children
from $1b exit to zebra

Authorizing premium user...